Laakmann, E., & Schneeweiss, A. (2019). Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. Breast cancer research, 21, . https://doi.org/10.1186/s13058-019-1144-x
Chicago-Zitierstil (17. Ausg.)Laakmann, Elena, und Andreas Schneeweiss. "Development of Central Nervous System Metastases as a First Site of Metastatic Disease in Breast Cancer Patients Treated in the Neoadjuvant Trials GeparQuinto and GeparSixto." Breast Cancer Research 21 (2019). https://doi.org/10.1186/s13058-019-1144-x.
MLA-Zitierstil (9. Ausg.)Laakmann, Elena, und Andreas Schneeweiss. "Development of Central Nervous System Metastases as a First Site of Metastatic Disease in Breast Cancer Patients Treated in the Neoadjuvant Trials GeparQuinto and GeparSixto." Breast Cancer Research, vol. 21, 2019, https://doi.org/10.1186/s13058-019-1144-x.